YieldMax MRNA Option Income Strategy ETF (MRNY) to Issue Dividend of $0.00 on December 31st

YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY) announced a dividend on Monday, December 29th. Investors of record on Tuesday, December 30th will be paid a dividend of 0.0002 per share on Wednesday, December 31st. This represents a yield of 6.0%. The ex-dividend date is Tuesday, December 30th.

YieldMax MRNA Option Income Strategy ETF Trading Down 1.9%

MRNY stock opened at $15.13 on Wednesday. YieldMax MRNA Option Income Strategy ETF has a 12-month low of $13.60 and a 12-month high of $56.65. The company has a 50 day moving average of $15.55 and a two-hundred day moving average of $18.78.

Institutional Investors Weigh In On YieldMax MRNA Option Income Strategy ETF

An institutional investor recently raised its position in YieldMax MRNA Option Income Strategy ETF stock. OLD Mission Capital LLC boosted its holdings in shares of YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY) by 235.0% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 99,034 shares of the company’s stock after buying an additional 69,476 shares during the quarter. OLD Mission Capital LLC owned about 0.34% of YieldMax MRNA Option Income Strategy ETF worth $273,000 at the end of the most recent quarter.

About YieldMax MRNA Option Income Strategy ETF

The YieldMax MRNA Option Income Strategy ETF (MRNY) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide current income and capped gains on the Moderna stock (MRNA) through a synthetic covered call strategy, collateralized by cash and US Treasurys. The actively managed fund uses both standardized exchange-traded and FLEX options. MRNY was launched on Oct 23, 2023 and is issued by YieldMax.